November 17, 2017 | City of Hope
City of Hope is now offering the first-ever FDA-approved CAR-T cell therapy for adult patients with certain types of large B-cell lymphoma who have not responded to or who have relapsed after at least two other kinds of treatment.
December 1, 2017 | City of Hope
Researchers developed a self-administered geriatric assessment to identify areas of vulnerability and guide interventions for older adults with cancer.
October 27, 2016 | Sumanta K. Pal, M.D.
Molecular profiling, unlike any other type of controversial profiling in the news, is an extremely hot topic in cancer medicine today, and it’s going to have a huge impact on patients, physicians and payers.